News

• January 8, 2014
  

  FDA releases Guidance for Drug Development Tool Qualification

• January 8, 2014
  

  EMA updates guidance for Qualification of Novel Methodologies for Drug Development

• January 3, 2014
  

  An Expanded Role for Patients in Clinical Trial Design – Podcast

  A discussion with Dr. Anne Rowzee of the Center for Drug Evaluation and Research, US FDA about patient input into the design of studies of medicines for multiple sclerosis.–Therapeutic Innovation & Regulatory Science Podcast Series – November 2013 Download MP3
• December 2, 2013
  

  C-Path’s Alzheimer’s Disease Simulator Featured in the Wall Street Journal

• September 10, 2013
  

  C-Path cosponsors Alzheimer’s workshop

  C-Path cosponsors workshop on combination drug development for Alzheimer’s disease Combination therapy development has been successful in other life-threatening diseases in part because collaborative approaches were established to identify necessary pathways and tools that enabled more efficient trials. The primary goal of this meeting held in Baltimore, MD November 29th 2012 was to explore how...